Amylin at the Interface between Metabolic and Neurodegenerative Disorders
The pancreatic peptide amylin is best known for its role as a satiation hormone in the control of food intake and as the major component of islet amyloid deposits in the pancreatic islets of patients with type 2 diabetes mellitus (T2DM). Epidemiological studies have established a clear association b...
Main Authors: | Thomas Alexander Lutz, Urs eMeyer |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-06-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fnins.2015.00216/full |
Similar Items
-
Amylin under examination. Fibrillogenic potential of the troublesome molecule
by: Małgorzata Marszałek
Published: (2018-04-01) -
The Role of NADPH Oxidases and Oxidative Stress in Neurodegenerative Disorders
by: Anuradha Tarafdar, et al.
Published: (2018-11-01) -
Mono and dual agonists of the amylin, calcitonin, and CGRP receptors and their potential in metabolic diseases
by: Nina Sonne, et al.
Published: (2021-04-01) -
Relation between serum amylin level and epilepsy
by: Necla Benlier, et al.
Published: (2020-03-01) -
Insulin Signal Transduction Perturbations in Insulin Resistance
by: Mariyam Khalid, et al.
Published: (2021-08-01)